We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
The Convention on Biological Diversity (CBD) was signed by 150 government leaders 30 years ago at the 1992 Rio Earth Summit, and recognizes intrinsic value of biodiversity and the importance of conservation and sustainable use of plant genetic resources to fulfil the food, health and other necessities of the growing world population. The CBD is supported in the implementation of its third objective, the fair and equitable sharing of benefits arising out of the utilization of genetic resources by the Nagoya Protocol on Access and Benefit Sharing (ABS) which came into force almost 8 years ago on 12 October 2014. We are still grappling with the question of whether the ABS system that has been implemented through national governments is effective in realising its objectives.
The panel consisting of experts from Brazil, India and South Africa will explore some of the challenges in developing countries relating access and the sharing of benefits, and consider how best to achieve tangible results through licensing and bioprospecting agreements.
Read about the Panellists here.
This event is free to participants.
